Pretreatment glucose status determines HCC development in HCV patients with mild liver disease after curative antiviral therapy

Although diabetes mellitus (DM) is known to increase the risk of hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), the impact of dynamic glucose status on HCC occurrence in chronic hepatitis C (CHC) patients receiving antiviral therapy is unclear. In total, 1112 biopsy-proven patients...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Medicine (Baltimore)
Prif Awduron: Huang, Chung-Feng, Yeh, Ming-Lun, Huang, Cing-Yi, Tsai, Pei-Chien, Ko, Yu-Min, Chen, Kuan-Yu, Lin, Zu-Yau, Chen, Shinn-Cherng, Dai, Chia-Yen, Chuang, Wan-Long, Huang, Jee-Fu, Yu, Ming-Lung
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Wolters Kluwer Health 2016
Pynciau:
4500
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5058864/
https://ncbi.nlm.nih.gov/pubmed/27399135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000004157
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg